» Articles » PMID: 22552885

Phosphate Homeostasis and Its Role in Bone Health

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2012 May 4
PMID 22552885
Citations 140
Authors
Affiliations
Soon will be listed here.
Abstract

Phosphate is one of the most abundant minerals in the body, and its serum levels are regulated by a complex set of processes occurring in the intestine, skeleton, and kidneys. The currently known main regulators of phosphate homeostasis include parathyroid hormone (PTH), calcitriol, and a number of peptides collectively known as the "phosphatonins" of which fibroblast growth factor-23 (FGF-23) has been best defined. Maintenance of extracellular and intracellular phosphate levels within a narrow range is important for many biological processes, including energy metabolism, cell signaling, regulation of protein synthesis, skeletal development, and bone integrity. The presence of adequate amounts of phosphate is critical for the process of apoptosis of mature chondrocytes in the growth plate. Without the presence of this mineral in high enough quantities, chondrocytes will not go into apoptosis, and the normal physiological chain of events that includes invasion of blood vessels and the generation of new bone will be blocked, resulting in rickets and delayed growth. In the rest of the skeleton, hypophosphatemia will result in osteomalacia due to an insufficient formation of hydroxyapatite. This review will address phosphate metabolism and its role in bone health.

Citing Articles

Effect of a single-dose denosumab on mineral homeostasis in infertile men: insights from a pilot intervention study and a randomized controlled trial.

Yahyavi S, Holt R, Juel Mortensen L, Boisen I, Arting L, Jorgensen A BMC Med. 2025; 23(1):145.

PMID: 40055742 PMC: 11887268. DOI: 10.1186/s12916-025-03958-7.


Dairy consumption has a partial inverse association with systolic blood pressure and hypertension in populations with high salt and low dairy diets: cross-sectional data analysis from the Iwaki Health Promotion Project.

Kawata D, Ueno H, Nakano A, Tatara Y, Tamada Y, Mikami T Hypertens Res. 2025; .

PMID: 39843856 DOI: 10.1038/s41440-024-02088-6.


Structural basis of phosphate export by human XPR1.

He Q, Zhang R, Tury S, Courgnaud V, Liu F, Battini J Nat Commun. 2025; 16(1):683.

PMID: 39814721 PMC: 11736019. DOI: 10.1038/s41467-025-55995-8.


Hypophosphataemia in Critical Illness: A Narrative Review.

Ramanan M, Tabah A, Affleck J, Edwards F, White K, Attokaran A J Clin Med. 2024; 13(23).

PMID: 39685625 PMC: 11642287. DOI: 10.3390/jcm13237165.


PER1 Oscillation in Rat Parathyroid Hormone and Calcitonin Producing Cells.

Georg B, Jorgensen H, Hannibal J Int J Mol Sci. 2024; 25(23).

PMID: 39684716 PMC: 11641806. DOI: 10.3390/ijms252313006.


References
1.
Wang H, Yoshiko Y, Yamamoto R, Minamizaki T, Kozai K, Tanne K . Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res. 2008; 23(6):939-48. DOI: 10.1359/jbmr.080220. View

2.
Ramon I, Kleynen P, Body J, Karmali R . Fibroblast growth factor 23 and its role in phosphate homeostasis. Eur J Endocrinol. 2009; 162(1):1-10. DOI: 10.1530/EJE-09-0597. View

3.
Dardenne O, Prudhomme J, Glorieux F, St-Arnaud R . Rescue of the phenotype of CYP27B1 (1alpha-hydroxylase)-deficient mice. J Steroid Biochem Mol Biol. 2004; 89-90(1-5):327-30. DOI: 10.1016/j.jsbmb.2004.03.026. View

4.
Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T . Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004; 113(4):561-8. PMC: 338262. DOI: 10.1172/JCI19081. View

5.
Yoshiko Y, Wang H, Minamizaki T, Ijuin C, Yamamoto R, Suemune S . Mineralized tissue cells are a principal source of FGF23. Bone. 2007; 40(6):1565-73. DOI: 10.1016/j.bone.2007.01.017. View